MedTrace Logo

Evaluation of Patients With Diffuse Parenchymal Lung Diseases Regarding Frailty

NCT06171425 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2023-12-19

No results posted yet for this study

Summary

There are very few studies in the literature examining the frailty levels of diffuse parenchymal lung disease (DPLD) patients and its effect on their functional status despite the high prevalance of frailty in patients with DPLD This observational study aims to learn about the relationship between frailty and functional capacity and balance in DPLD patients compared to healthy subjects.

Conditions

  • Diffuse Parenchymal Lung Disease
  • Frailty
  • Physical Inactivity

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-25
Primary Completion
2024-01-01
Completion
2024-02-22

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06171425 on ClinicalTrials.gov